18.05.2022 15:25

New Janssen Campaign Developed by and for the LGBTQ+ Community Inspires Action and Empathy for People Living with Depression

Folgen
Werbung
TITUSVILLE, NJ, May 18, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Depression Looks Like Me, a campaign aimed at normalizing the conversation about depression in the LGBTQ+ community and empowering people to seek the mental health care they may need. Janssen has partnered with prominent LGBTQ+ voices and leading mental health and LGBTQ+ advocacy organizations to amplify lived experiences across the community and underscore that those living with hard-to-treat depression are not alone. Depression is a serious and chronic health condition that disproportionally affects members of the LGBTQ+ community, likely due to significant stigma and discrimination often faced.1 LGBTQ+ adults are three times as likely to have mental health conditions compared to heterosexual adults2 and are 2.5 times more likely to use mental health services than cisgender heterosexual adults.3 The campaign and its corresponding website offer a safe space in which the community can see themselves represented in stories, gain access to culturally appropriate resources and providers across intersections of the community, and learn about the different facets of depression so they can make informed decisions with their healthcare teams about their treatment plans.Depression Looks Like Me provides clear and easy access to carefully curated information, including directories for LGBTQ+-friendly healthcare professionals and confidential, trained counselors. Specific resources for Black, Indigenous, and People of Color (BIPOC) and transgender people are also available, as are general mental health resources.“Living with depression can make it hard to find a safe space or someone with whom you feel you can confide in. If you do not feel yourself represented, it can be even more challenging to see how you yourself fit in or figure out what you can do to take action,” said campaign partner Ren Fernandez-Kim, who lives with depression. “As a nonbinary, mixed race person, I often felt stuck and overlooked, despite my desire to heal. Through communities like Depression Looks Like Me, we can come together to lift one another up. I find beauty in knowing I am not alone.” At the heart of the campaign are impactful personal stories to help individuals connect through their experiences with depression in ways that offer perspective and create a sense of community. These stories—which showcase the intersection of identity and mental health—are designed to inspire patients, caregivers, and allies to add their own voices to the campaign. “Seeing ourselves reflected in the experiences of others is a fundamental step in recognizing and seeking care, especially within the LGBTQ+ community. That’s one of the reasons we’re happy to be part of Depression Looks Like Me. Through representation, the campaign aims to create equity, help eliminate health disparities, enhance quality of life and improve health outcomes, which are core values of our Coalition,” said Scott D. Bertani, Director of Advocacy, the National Coalition for LGBTQ Health. “Together, we can help make mental and behavioral health services more accessible and pave the way to improve the health and wellness of the LGBTQ+ community in ways that aren’t diagnosis-limiting or identity-defining.”To ensure the broad spectrum of the community’s needs are represented in this campaign, Janssen, along with the National Coalition for LGBTQ Health, is also working with Mental Health America (MHA), SAGE, National Alliance on Mental Illness (NAMI), The TransLatin@ Coalition and Black Emotional and Mental Health Collective (BEAM) to share and extend the reach of resources that address the diverse needs of the community. Resources and information are critical for the community to have informed conversations with their healthcare teams, especially about mental health and depression, which have many dimensions. Major depressive disorder (MDD), also known as clinical depression, is so much more than simply feeling sad. It is a serious mental illness with variable symptoms that may include persistent feelings of sadness, hopelessness or tension; changes in sleep or appetite; difficulty concentrating or performing activities of daily living; lack of interest; and or thoughts of self-harm or suicide.4For some people, symptoms of depression persist even after treatment. When people do not respond to two or more antidepressants (of adequate dose and duration), they may have treatment-resistant depression (TRD).5 Some patients also have a more severe form of MDD, where a person experiences a sudden worsening of depressive symptoms, which can cause them to start actively considering suicide and require urgent intervention to treat their symptoms.6 “Depression is a serious, life-altering medical condition that’s further complicated for the LGBTQ+ community by stigma and lack of culturally competent care that means many go undiagnosed, untreated and suffer in silence,” said Courtney Billington, President, Neuroscience, Janssen Pharmaceuticals, Inc. “That’s why we partnered with members and leaders of the mental health and LGBTQ+ communities to create Depression Looks Like Me—to work together and show the community they are seen, heard and worthy of receiving care to meet their specific needs.”Depression Looks Like Me is part of Johnson & Johnson's broader initiative, Our Race to Health Equity – a $100 million commitment to help eradicate racial and social injustice as a public health threat. This campaign supports the company’s commitment to eliminate health disparities in the diagnosis and treatment of serious mental illness, educate and empower people of color around mental health, and improve access to mental health care for people and communities who have been historically excluded.About the Janssen Pharmaceutical Companies of Johnson & JohnsonAt Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism & Retina, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.Learn more at www.janssen.com. Follow us at www.twitter.com/JanssenUS and www.twitter.com/JanssenGlobal. Janssen Pharmaceuticals, Inc. is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.# # #REFERENCES1. Depression. Accessed January 4, 2022. https://www.mhanational.org/conditions/depression 2. LGBTQ+. Accessed January 11, 2022. https://adaa.org/find-help/by-demographics/lgbtq3. LGBTQ+ Communities and Mental Health. Accessed January 10, 2022. https://www.mhanational.org/issues/lgbtq-communities-and-mental-health 4. What Is Depression? Accessed January 13, 2022. https://www.psychiatry.org/patients-families/depression/what-is-depression 5. Agency for Healthcare Research and Quality. Treatment-Resistant Depression: A Narrative and Systematic Review of Definitions and Methods in Clinical Research Studies. Accessed January 4, 2022. https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/trdepression-protocol-amendment.pdf 6. Depression. Accessed January 13, 2022. https://www.who.int/en/news-room/fact-sheets/
Weiter zum vollständigen Artikel bei "Johnson & Johnson"
Ausgewählte Hebelprodukte auf Johnson & Johnson
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Johnson & Johnson
Long
Short
Hebel wählen:
5x
10x
Name
Hebel
KO
Emittent
Quelle: EN, Johnson & Johnson

Nachrichten zu Johnson & Johnson

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Johnson & Johnson

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
01.06.2021JohnsonJohnson OutperformCredit Suisse Group
13.10.2020JohnsonJohnson OutperformCredit Suisse Group
27.08.2019JohnsonJohnson kaufenGoldman Sachs Group Inc.
27.08.2019JohnsonJohnson OutperformCredit Suisse Group
16.07.2019JohnsonJohnson OutperformCredit Suisse Group
01.06.2021JohnsonJohnson OutperformCredit Suisse Group
13.10.2020JohnsonJohnson OutperformCredit Suisse Group
27.08.2019JohnsonJohnson kaufenGoldman Sachs Group Inc.
27.08.2019JohnsonJohnson OutperformCredit Suisse Group
16.07.2019JohnsonJohnson OutperformCredit Suisse Group
23.01.2019JohnsonJohnson Equal WeightBarclays Capital
21.07.2016JohnsonJohnson HoldDeutsche Bank AG
13.06.2016JohnsonJohnson NeutralGoldman Sachs Group Inc.
27.01.2016JohnsonJohnson HaltenIndependent Research GmbH
21.01.2016JohnsonJohnson HaltenIndependent Research GmbH
17.04.2018JohnsonJohnson SellGoldman Sachs Group Inc.
21.07.2017JohnsonJohnson SellBTIG Research
20.05.2016JohnsonJohnson SellStandpoint Research
17.10.2012JohnsonJohnson verkaufenIndependent Research GmbH
10.10.2012JohnsonJohnson sellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Johnson & Johnson nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen

Jetzt noch kostenlos anmelden!

Inflation, Leitzinserhöhung und Bärenmärkte - aber wie sieht es eigentlich am Immobilienmarkt aus? Wenn auch Sie sich den Traum einer eigenen Immobilie erfüllen möchten, erfahren Sie im Online-Seminar am Montag um 18 Uhr wie Sie Schritt für Schritt das passende Objekt finden und welche Finanzierungsmöglichkeiten es gibt!

Werbung
Werbung
Werbung
Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Ukraine-Krieg im Ticker: DAX schließt Freitagshandel über 13.100 Punkten -- US-Börsen legen markant zu -- Zalando kassiert Jahresprognose -- GAZPROM, TUI, Porsche-IPO, Amazon, Deutsche Bank im Fokus

IMMOFINANZ will Objekte in Milliardenwert verkaufen. Streik des Kabinen-Personals führt zu Flug-Ausfällen bei Ryanair. Henkel macht laut CEO Knobel Fortschritte beim Rückzug aus Russland. RWE plant Wasserstoff-Produktionsanlage in Rostock. Stellantis steigt bei Lithium-Unternehmen Vulcan Energy ein. Stifel startet Vonovia mit "Hold". Zurich trennt sich von deutschen Lebensversicherungs-Altbeständen.

Umfrage

Sollte das 9-Euro-Ticket über den August hinaus verlängert werden?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln